We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Apple, Berkshire Hathaway, Johnson & Johnson, Lockheed Martin and PNC Financial Services Group
Read MoreHide Full Article
For Immediate Release
Chicago, IL – December 4, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (AAPL - Free Report) , Berkshire Hathaway Inc. (BRK.B - Free Report) , Johnson & Johnson (JNJ - Free Report) , Lockheed Martin Corp. (LMT - Free Report) and The PNC Financial Services Group, Inc. (PNC - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Apple, Berkshire Hathaway and Johnson & Johnson
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple, Berkshire Hathaway and Johnson & Johnson. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Apple shares have outperformed the S&P 500 in the year-to-date period (+67.6% vs. +14.2%) on the back of continued momentum in the Services segment, driven by a robust performance of App Store, Apple Music, video, and cloud services. Moreover, iPad, Mac and Wearables contributed strongly to the quarterly results. However, iPhone sales declined in the September-quarter release due to weakness in China and absence of the new iPhone.
Nevertheless, Apple’s near-term prospects are bright, driven by new iPhones that support 5G, revamped iPad and Mac line-up of devices, health-focused Apple Watch 6 and robust growth in the Services business.
Shares of Berkshire Hathaway have gained +5.5% over the past year against the Zacks Insurance - Property and Casualty industry’s loss of -2.2%. The Zacks analyst believes that the company’s inorganic growth story remains impressive with strategic acquisitions. A strong cash position supports earnings-accretive bolt-on buyouts and indicates the company's financial flexibility. Continued insurance business growth fuels increase in float, drives earnings and generates maximum return on equity.
However, exposure to catastrophe loss induces earnings volatility and also affects the property and casualty underwriting results of the company. Huge capital expenditure remains a headwind for the company.
Johnson & Johnson shares have gained +1.6% in the year-to-date period against the Zacks Large Cap Pharmaceuticals industry’s rise of +2.2%. J&J faces numerous lawsuits, which allege personal injuries to patients caused by the use of its products. The Zacks analysts believes that these lawsuits have resulted in uncertainties. At the same time, headwinds like generic competition and pricing pressure continue.
However, the company has raised its 2020 outlook due to faster-than-expected recovery in the Medical Devices unit with trends expected to improve further in Q4 and 2021. The Pharma unit is performing at above-market levels, supported by successful label expansion of blockbuster drugs, Imbruvica, Darzalex and Stelara. J&J is also making rapid progress with its pipeline and line extensions. Several pivotal data readouts are expected in the near-term.
Other noteworthy reports we are featuring today include Lockheed Martin and The PNC Financial Services Group.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Apple, Berkshire Hathaway, Johnson & Johnson, Lockheed Martin and PNC Financial Services Group
For Immediate Release
Chicago, IL – December 4, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (AAPL - Free Report) , Berkshire Hathaway Inc. (BRK.B - Free Report) , Johnson & Johnson (JNJ - Free Report) , Lockheed Martin Corp. (LMT - Free Report) and The PNC Financial Services Group, Inc. (PNC - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Apple, Berkshire Hathaway and Johnson & Johnson
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple, Berkshire Hathaway and Johnson & Johnson. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Apple shares have outperformed the S&P 500 in the year-to-date period (+67.6% vs. +14.2%) on the back of continued momentum in the Services segment, driven by a robust performance of App Store, Apple Music, video, and cloud services. Moreover, iPad, Mac and Wearables contributed strongly to the quarterly results. However, iPhone sales declined in the September-quarter release due to weakness in China and absence of the new iPhone.
Nevertheless, Apple’s near-term prospects are bright, driven by new iPhones that support 5G, revamped iPad and Mac line-up of devices, health-focused Apple Watch 6 and robust growth in the Services business.
(You can read the full research report on Apple here >>>)
Shares of Berkshire Hathaway have gained +5.5% over the past year against the Zacks Insurance - Property and Casualty industry’s loss of -2.2%. The Zacks analyst believes that the company’s inorganic growth story remains impressive with strategic acquisitions. A strong cash position supports earnings-accretive bolt-on buyouts and indicates the company's financial flexibility. Continued insurance business growth fuels increase in float, drives earnings and generates maximum return on equity.
However, exposure to catastrophe loss induces earnings volatility and also affects the property and casualty underwriting results of the company. Huge capital expenditure remains a headwind for the company.
(You can read the full research report on Berkshire Hathaway here >>>)
Johnson & Johnson shares have gained +1.6% in the year-to-date period against the Zacks Large Cap Pharmaceuticals industry’s rise of +2.2%. J&J faces numerous lawsuits, which allege personal injuries to patients caused by the use of its products. The Zacks analysts believes that these lawsuits have resulted in uncertainties. At the same time, headwinds like generic competition and pricing pressure continue.
However, the company has raised its 2020 outlook due to faster-than-expected recovery in the Medical Devices unit with trends expected to improve further in Q4 and 2021. The Pharma unit is performing at above-market levels, supported by successful label expansion of blockbuster drugs, Imbruvica, Darzalex and Stelara. J&J is also making rapid progress with its pipeline and line extensions. Several pivotal data readouts are expected in the near-term.
(You can read the full research report on Johnson & Johnson here >>>)
Other noteworthy reports we are featuring today include Lockheed Martin and The PNC Financial Services Group.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.